Editorial: a pipe dream fulfilled? A therapeutic option for fatigue in IBD. Authors' reply

被引：0
|
作者：
Bager, Palle [1 ]
Hvas, Christian Lodberg [1 ]
Rud, Charlotte Lock [1 ]
Dahlerup, Jens Frederik [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus N, Denmark
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2021年 / 53卷 / 02期
关键词：
D O I：
10.1111/apt.16209
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：344 / 345
页数：2
相关论文
共 30 条
  • [1] Editorial: a pipe dream fulfilled? A therapeutic option for fatigue in IBD
    LeBlanc, Jean-Frederic
    Hart, Ailsa L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (02) : 342 - 343
  • [2] Editorial: Updated COVID-19 Boosters-Tailoring Protection for Patients With IBD. Authors' Reply
    Woelfel, Simon
    Brand, Stephan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (02) : 382 - 383
  • [3] Editorial: Unravelling the fibres-low dietary fibre may lower risk of developing IBD. Authors' reply
    Dan, Lintao
    Wang, Xiaoyan
    Chen, Jie
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (09) : 940 - 941
  • [4] Editorial: IBD and sleep-authors' reply
    Yuan, Shuai
    Chen, Jie
    Li, Xue
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (05) : 575 - 576
  • [5] Letter: vedolizumab or a second anti-TNF-no difference in efficacy for primary biologic failures with IBD. Authors' reply
    Rundquist, Sara
    Sachs, Michael C.
    Eriksson, Carl
    Olen, Ola
    Montgomery, Scott
    Halfvarson, Jonas
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (09) : 1046 - 1047
  • [6] Editorial: suicide and IBD-a call to action. Authors' reply
    Malham, Mikkel
    Jakobsen, Christian
    Hald, Mette
    Paerregaard, Anders
    Virta, Lauri J.
    Kolho, Kaija-Leena
    Wewer, Vibeke
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (01) : 106 - 107
  • [7] Authors' reply to: Could statins be a real therapeutic option for the treatment of hepatitis C?
    Malaguarnera, Michele
    Vacante, Marco
    Giordano, Maria
    Malaguarnera, Mariano
    Galvano, Fabio
    Volti, Giovanni Li
    HEPATITIS MONTHLY, 2011, 11 (07) : 563 - 564
  • [8] Editorial: is thalidomide a good option for patients with refractory Crohn's disease? Authors' reply
    Gerich, M.
    Yoon, J.
    Vasiliauskas, E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (08) : 786 - 786
  • [9] Editorial: is there a role for monitoring intermediate anti-TNF drug concentrations in IBD? Authors' reply
    Roblin, Xavier
    Paul, Stephane
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (08) : 1051 - 1051
  • [10] Editorial: the influence of genetic factors in mediating the effects of tobacco smoke in IBD-Authors' reply
    Lang, B. M.
    Beerenwinkel, N.
    Misselwitz, B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (02) : 307 - 308
123